Diane returns to French market for acne under strict conditions
This article was originally published in Scrip
Executive Summary
Bayer's anti-acne product Diane 35 (cyproterone/ethinylestradiol) and its generic versions are now being reintroduced to the French market under strict prescribing conditions, following last year's safety review by the European Medicines Agency's pharmacovigilance risk assessment committee (PRAC).